All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
During the EHA2021 Virtual Congress, the MPN Hub spoke with Tiziano Barbui, Papa Giovanni XXIII Hospital, Bergamo, IT. We asked, What are the long-term effects of COVID-19 in patients with myeloproliferative neoplasms (MPN)?
What are the long-term effects of COVID-19 in patients with MPN?
In this video, Barbui discusses the findings from a European observational study on the epidemiology of COVID-19 in patients with MPN. The study consisted of 180 patients from European countries and looked at mortality rates and incidence of thrombosis.
EPICOVIDEHA registry: Epidemiology and outcomes in patients with hematologic malignancies infected with COVID-19
Patients with hematologic malignancies (HMs) may have intensified immune dysregulation resulting from both therapeutic agents and...
COVID-19 vaccination for hematopoietic stem cell transplant patients
The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular, patients with hematologic malignancies have been...
Subscribe to get the best content related to MPN delivered to your inbox